Second Sight Medical Products Stock Price, News & Analysis (NASDAQ:EYES)

$1.60 +0.04 (+2.56 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$1.60
Today's Range$1.54 - $1.60
52-Week Range$0.90 - $2.58
Volume329,310 shs
Average Volume761,539 shs
Market Capitalization$93.22 million
P/E Ratio-2.39
Dividend YieldN/A
Beta3.45

About Second Sight Medical Products (NASDAQ:EYES)

Second Sight Medical Products logoSecond Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company's product, the Argus II System, treats outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. It does not restore normal vision and it does not slow or reverse the progression of the disease. The Company's Argus II System employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals. The Argus II System works by converting video images captured by a miniature camera housed in a patient's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes that are implanted on the surface of the retina.

Receive EYES News and Ratings via Email

Sign-up to receive the latest news and ratings for EYES and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices & Implants
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:EYES
CUSIPN/A
Phone+1-818-8335000

Debt

Debt-to-Equity RatioN/A
Current Ratio2.90%
Quick Ratio2.37%

Price-To-Earnings

Trailing P/E Ratio-2.38805970149254
Forward P/E Ratio-2.91
P/E GrowthN/A

Sales & Book Value

Annual Sales$3.98 million
Price / Sales22.84
Cash FlowN/A
Price / CashN/A
Book Value$0.26 per share
Price / Book6.15

Profitability

Trailing EPS($0.67)
Net Income$-33,170,000.00
Net Margins-565.12%
Return on Equity-184.87%
Return on Assets-137.77%

Miscellaneous

Employees110
Outstanding Shares56,810,000

Second Sight Medical Products (NASDAQ:EYES) Frequently Asked Questions

What is Second Sight Medical Products' stock symbol?

Second Sight Medical Products trades on the NASDAQ under the ticker symbol "EYES."

How were Second Sight Medical Products' earnings last quarter?

Second Sight Medical Products Inc (NASDAQ:EYES) released its quarterly earnings results on Thursday, November, 2nd. The medical device company reported ($0.12) EPS for the quarter, beating the Zacks' consensus estimate of ($0.14) by $0.02. The medical device company had revenue of $1.61 million for the quarter, compared to analyst estimates of $1.54 million. Second Sight Medical Products had a negative net margin of 565.12% and a negative return on equity of 184.87%. View Second Sight Medical Products' Earnings History.

When will Second Sight Medical Products make its next earnings announcement?

Second Sight Medical Products is scheduled to release their next quarterly earnings announcement on Wednesday, March, 7th 2018. View Earnings Estimates for Second Sight Medical Products.

Where is Second Sight Medical Products' stock going? Where will Second Sight Medical Products' stock price be in 2018?

1 analysts have issued 12-month price objectives for Second Sight Medical Products' shares. Their forecasts range from $5.00 to $5.00. On average, they expect Second Sight Medical Products' share price to reach $5.00 in the next twelve months. View Analyst Ratings for Second Sight Medical Products.

What are Wall Street analysts saying about Second Sight Medical Products stock?

Here are some recent quotes from research analysts about Second Sight Medical Products stock:

  • 1. According to Zacks Investment Research, "Second Sight Medical Products, Inc. is a medical device company. It develops, manufactures, and markets implantable prosthetic devices to restore some functional vision to blind patients. The Company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations, such as retinitis pigmentosa. Second Sight Medical Products, Inc. is headquartered in Sylmar, California. " (1/8/2018)
  • 2. HC Wainwright analysts commented, "We expect that the second pilot study could start in late 3Q17 or early 4Q17 and report top-line data by the end of 2017. Investors may recall that this second pilot study is double-masked and slated to enroll up to 45 subjects. The primary endpoint is the percentage of subjects achieving complete wound healing (based on staining) on day 3. Assuming that the second pilot study shows OBG’s ability to heal corneal defects faster than the standard of care, as was seen in the first pilot study, we believe that EyeGate may only need to conduct a single pivotal study in 2018 before filing for regulatory approval. We note that the FDA has permitted EyeGate to pursue U.S. regulatory clearance for OBG through the de novo 510(k) pathway." (8/8/2017)

Who are some of Second Sight Medical Products' key competitors?

Who are Second Sight Medical Products' key executives?

Second Sight Medical Products' management team includes the folowing people:

  • Robert J. Greenberg M.D. Ph.D., Chairman of the Board (Age 49)
  • Jonathan McGuire, President, Chief Executive Officer, Director (Age 54)
  • Frank Vandeputte, Vice President, General Manager
  • Stephen D. Okland Jr., Commercial Vice President, U.S. and Canada (Age 53)
  • Edward David Randolph, Vice President - Manufacturing (Age 59)
  • David Murray Jacques, Vice President - Research & Development (Age 54)
  • William J. Link Ph.D., Independent Director (Age 71)
  • Aaron Mendelsohn, Independent Director (Age 66)
  • Matthew Jonathan Pfeffer, Independent Director (Age 60)
  • Gregg Williams, Independent Director (Age 58)

When did Second Sight Medical Products IPO?

(EYES) raised $32 million in an initial public offering (IPO) on Wednesday, November 19th 2014. The company issued 3,500,000 shares at $9.00 per share. MDB Capital Group, LLC served as the underwriter for the IPO.

Who owns Second Sight Medical Products stock?

Second Sight Medical Products' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.70%), Millennium Management LLC (0.21%), HBK Sorce Advisory LLC (0.17%) and Sigma Planning Corp (0.13%). Company insiders that own Second Sight Medical Products stock include Edward David Randolph, Gregg Williams and Robert J Greenberg. View Institutional Ownership Trends for Second Sight Medical Products.

Who sold Second Sight Medical Products stock? Who is selling Second Sight Medical Products stock?

Second Sight Medical Products' stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC. View Insider Buying and Selling for Second Sight Medical Products.

Who bought Second Sight Medical Products stock? Who is buying Second Sight Medical Products stock?

Second Sight Medical Products' stock was bought by a variety of institutional investors in the last quarter, including Virtu Financial LLC, Sigma Planning Corp and HBK Sorce Advisory LLC. View Insider Buying and Selling for Second Sight Medical Products.

How do I buy Second Sight Medical Products stock?

Shares of Second Sight Medical Products can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Second Sight Medical Products' stock price today?

One share of Second Sight Medical Products stock can currently be purchased for approximately $1.60.

How big of a company is Second Sight Medical Products?

Second Sight Medical Products has a market capitalization of $93.22 million and generates $3.98 million in revenue each year. The medical device company earns $-33,170,000.00 in net income (profit) each year or ($0.67) on an earnings per share basis. Second Sight Medical Products employs 110 workers across the globe.

How can I contact Second Sight Medical Products?

Second Sight Medical Products' mailing address is 12744 San Fernando Rd Bldg 3, SYLMAR, CA 91342-3853, United States. The medical device company can be reached via phone at +1-818-8335000 or via email at [email protected]


MarketBeat Community Rating for Second Sight Medical Products (EYES)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  108 (Vote Outperform)
Underperform Votes:  112 (Vote Underperform)
Total Votes:  220
MarketBeat's community ratings are surveys of what our community members think about Second Sight Medical Products and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Second Sight Medical Products (NASDAQ:EYES) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.00$5.00$5.00$5.00
Price Target Upside: 116.45% upside339.44% upside339.44% upside342.48% upside

Second Sight Medical Products (NASDAQ:EYES) Consensus Price Target History

Price Target History for Second Sight Medical Products (NASDAQ:EYES)

Second Sight Medical Products (NASDAQ:EYES) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/5/2018HC WainwrightSet Price TargetBuy$5.00HighView Rating Details
7/26/2016Rodman & RenshawReiterated RatingBuy$16.00N/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Second Sight Medical Products (NASDAQ:EYES) Earnings History and Estimates Chart

Earnings by Quarter for Second Sight Medical Products (NASDAQ:EYES)

Second Sight Medical Products (NASDAQ EYES) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2018N/AView Earnings Details
11/2/2017Q3 2017($0.14)($0.12)$1.54 million$1.61 millionViewN/AView Earnings Details
8/1/2017Q2 2017($0.14)($0.13)$1.43 million$2.24 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.14)($0.18)$1.32 million$1.01 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.17)($0.24)$1.76 million$0.72 millionViewListenView Earnings Details
11/2/2016Q316($0.16)($0.15)$2.36 million$1.20 millionViewN/AView Earnings Details
7/28/2016Q216($0.15)($0.17)$2.66 million$1.04 millionViewListenView Earnings Details
4/28/2016Q116($0.16)($0.13)$1.38 million$1.05 millionViewListenView Earnings Details
3/3/2016Q415($0.14)($0.15)$2.47 million$2.40 millionViewN/AView Earnings Details
10/29/2015Q315($0.14)($0.13)$2.05 million$2.23 millionViewListenView Earnings Details
8/4/2015Q215($0.14)($0.14)$1.73 million$2.70 millionViewN/AView Earnings Details
5/13/2015Q115($0.12)$1.70 millionViewListenView Earnings Details
3/11/2015Q4 2014($0.18)$1.52 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Second Sight Medical Products (NASDAQ:EYES) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.55 EPS
Next Year EPS Consensus Estimate: $-0.58 EPS

Dividends

Dividend History for Second Sight Medical Products (NASDAQ:EYES)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Second Sight Medical Products (NASDAQ EYES) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 34.70%
Institutional Ownership Percentage: 13.75%
Insider Trades by Quarter for Second Sight Medical Products (NASDAQ:EYES)
Insider Trades by Quarter for Second Sight Medical Products (NASDAQ:EYES)

Second Sight Medical Products (NASDAQ EYES) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/20/2017Gregg WilliamsDirectorBuy17,020$1.18$20,083.60View SEC Filing  
11/17/2017Gregg WilliamsDirectorBuy5,420$1.17$6,341.40View SEC Filing  
4/7/2017Gregg WilliamsDirectorBuy4,000,000$1.00$4,000,000.00View SEC Filing  
12/1/2016Robert J GreenbergChairmanSell1,950$1.96$3,822.00172,911View SEC Filing  
6/3/2016Edward David RandolphVPSell5,104$4.01$20,467.04View SEC Filing  
6/2/2016Robert J GreenbergChairmanSell8,571$4.10$35,141.10172,911View SEC Filing  
4/18/2016Robert J GreenbergChairmanSell8,223$5.27$43,335.21181,134View SEC Filing  
12/7/2015Robert J. GreenbergChairmanSell17,969$5.30$95,235.70172,911View SEC Filing  
12/4/2015Anne-Marie Juliette RipleyVPSell2,500$5.50$13,750.00View SEC Filing  
6/4/2015Anne-Marie Juliette RipleyVPSell4,371$15.00$65,565.00View SEC Filing  
6/3/2015Robert J GreenbergCEOSell150,000$14.04$2,106,000.00View SEC Filing  
5/27/2015Anne-Marie Juliette RipleyVPSell45,629$13.04$595,002.16View SEC Filing  
3/23/2015Robert J GreenbergCEOSell100,000$13.28$1,328,000.00View SEC Filing  
11/19/2014Gregg WilliamsDirectorBuy111,111$9.00$999,999.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Second Sight Medical Products (NASDAQ EYES) News Headlines

Source:
DateHeadline
Second Sight Medical (EYES) Gains Following Entry into Singapore - StreetInsider.comSecond Sight Medical (EYES) Gains Following Entry into Singapore - StreetInsider.com
www.streetinsider.com - February 17 at 3:37 PM
Second Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis SystemSecond Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis System
finance.yahoo.com - February 16 at 9:59 AM
Second Sight Medical Products (EYES) vs. Amedica (AMDA) Head-To-Head ReviewSecond Sight Medical Products (EYES) vs. Amedica (AMDA) Head-To-Head Review
www.americanbankingnews.com - February 15 at 12:46 PM
First Look At Second Sight - Seeking AlphaFirst Look At Second Sight - Seeking Alpha
seekingalpha.com - February 8 at 5:16 AM
Second Sight Medical, Investors Open Their Eyes Making These Shares Soar, Recent DevelopmentsSecond Sight Medical, Investors Open Their Eyes Making These Shares Soar, Recent Developments
finance.yahoo.com - February 8 at 5:16 AM
Second Sight (EYES) Catches Eye: Stock Jumps 12.7% - NasdaqSecond Sight (EYES) Catches Eye: Stock Jumps 12.7% - Nasdaq
www.nasdaq.com - February 6 at 3:17 PM
Second Sight (EYES) Catches Eye: Stock Jumps 12.7%Second Sight (EYES) Catches Eye: Stock Jumps 12.7%
finance.yahoo.com - February 6 at 3:17 PM
Second Sight Medical Products Inc Execution Is Firing on All Cylinders Following Standout 4Q:17 ImplantsSecond Sight Medical Products Inc Execution Is Firing on All Cylinders Following Standout 4Q:17 Implants
finance.yahoo.com - February 6 at 3:17 PM
33 Biggest Movers From Yesterday - Benzinga33 Biggest Movers From Yesterday - Benzinga
www.benzinga.com - February 6 at 5:25 AM
31 Stocks Moving In Mondays Mid-Day Session | Benzinga - Benzinga31 Stocks Moving In Monday's Mid-Day Session | Benzinga - Benzinga
www.benzinga.com - February 6 at 5:25 AM
Pre-Open Movers 02/05: (CAPR) (EYES) (BG) Higher; (WFC) (DKS) (QCOM) Lower (more...) - StreetInsider.comPre-Open Movers 02/05: (CAPR) (EYES) (BG) Higher; (WFC) (DKS) (QCOM) Lower (more...) - StreetInsider.com
www.streetinsider.com - February 5 at 3:17 PM
Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; Crude Oil Down 2% - BenzingaMid-Afternoon Market Update: Dow Tumbles Over 400 Points; Crude Oil Down 2% - Benzinga
www.benzinga.com - February 5 at 3:17 PM
Second Sight Medical (EYES) Provides Update on Key Performance Metrics - StreetInsider.comSecond Sight Medical (EYES) Provides Update on Key Performance Metrics - StreetInsider.com
www.streetinsider.com - February 5 at 3:17 PM
Second Sight Announces Record Number of Argus II Retinal Prosthesis Systems Implants and Completes First-in-Human Orion Cortical ImplantSecond Sight Announces Record Number of Argus II Retinal Prosthesis Systems Implants and Completes First-in-Human Orion Cortical Implant
finance.yahoo.com - February 5 at 3:17 PM
 Second Sight Medical Products Inc (EYES) Given $5.00 Consensus Target Price by Analysts Second Sight Medical Products Inc (EYES) Given $5.00 Consensus Target Price by Analysts
www.americanbankingnews.com - February 3 at 3:22 PM
Pre-Market Technical Scan on Medical Equipment Equities -- Senseonics, Aethlon Medical, CHF Solutions, and ... - PR Newswire (press release)Pre-Market Technical Scan on Medical Equipment Equities -- Senseonics, Aethlon Medical, CHF Solutions, and ... - PR Newswire (press release)
www.prnewswire.com - January 22 at 7:45 AM
Zacks: Analysts Set $5.00 Price Target for Second Sight Medical Products Inc (EYES)Zacks: Analysts Set $5.00 Price Target for Second Sight Medical Products Inc (EYES)
www.americanbankingnews.com - January 22 at 1:20 AM
Second Sight Medical Products (EYES) Raised to Hold at Zacks Investment ResearchSecond Sight Medical Products (EYES) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - January 8 at 11:30 PM
January Growth Opportunities – Athenex And MoreJanuary Growth Opportunities – Athenex And More
finance.yahoo.com - December 31 at 5:05 PM
Comparing Second Sight Medical Products (EYES) & Its RivalsComparing Second Sight Medical Products (EYES) & Its Rivals
www.americanbankingnews.com - December 22 at 9:20 PM
Second Sight Medical Products (EYES) & Its Competitors Head-To-Head ReviewSecond Sight Medical Products (EYES) & Its Competitors Head-To-Head Review
www.americanbankingnews.com - December 20 at 9:32 AM
Second Sight Medical Products (EYES) vs. Its Rivals Head-To-Head ComparisonSecond Sight Medical Products (EYES) vs. Its Rivals Head-To-Head Comparison
www.americanbankingnews.com - December 19 at 3:26 PM
Critical Review: Second Sight Medical Products (EYES) versus The CompetitionCritical Review: Second Sight Medical Products (EYES) versus The Competition
www.americanbankingnews.com - December 19 at 9:32 AM
Zacks: Second Sight Medical Products, Inc. (EYES) Given $5.00 Average Target Price by BrokeragesZacks: Second Sight Medical Products, Inc. (EYES) Given $5.00 Average Target Price by Brokerages
www.americanbankingnews.com - December 18 at 3:28 PM
Second Sight Medical Products (EYES) versus Its Competitors Critical AnalysisSecond Sight Medical Products (EYES) versus Its Competitors Critical Analysis
www.americanbankingnews.com - December 17 at 1:28 AM
Second Sight Medical Products (EYES) & Its Rivals Financial ReviewSecond Sight Medical Products (EYES) & Its Rivals Financial Review
www.americanbankingnews.com - December 15 at 9:14 AM
Second Sight Medical Products (EYES) vs. Its Rivals Head to Head ComparisonSecond Sight Medical Products (EYES) vs. Its Rivals Head to Head Comparison
www.americanbankingnews.com - December 12 at 7:34 PM
ETFs with exposure to Second Sight Medical Products, Inc. : December 12, 2017ETFs with exposure to Second Sight Medical Products, Inc. : December 12, 2017
finance.yahoo.com - December 12 at 5:36 PM
Second Sight Medical Products (EYES) & Its Competitors Financial ReviewSecond Sight Medical Products (EYES) & Its Competitors Financial Review
www.americanbankingnews.com - December 11 at 11:24 AM
Second Sight Medical Products (EYES) vs. Its Peers Head to Head ReviewSecond Sight Medical Products (EYES) vs. Its Peers Head to Head Review
www.americanbankingnews.com - December 10 at 3:26 AM
Financial Review: Second Sight Medical Products (EYES) and Its RivalsFinancial Review: Second Sight Medical Products (EYES) and Its Rivals
www.americanbankingnews.com - December 7 at 3:38 PM
Second Sight Medical (EYES) in Focus: Stock Moves 12.1% HigherSecond Sight Medical (EYES) in Focus: Stock Moves 12.1% Higher
finance.yahoo.com - December 7 at 9:57 AM
Contrasting Second Sight Medical Products (EYES) and Its PeersContrasting Second Sight Medical Products (EYES) and Its Peers
www.americanbankingnews.com - December 6 at 9:10 PM
Second Sight Announces Market Entry into Iran with First Two Implants of Argus II Retinal Prosthesis System - Business Wire (press release)Second Sight Announces Market Entry into Iran with First Two Implants of Argus II Retinal Prosthesis System - Business Wire (press release)
www.businesswire.com - December 5 at 5:07 PM
Critical Analysis: Second Sight Medical Products (EYES) versus Its RivalsCritical Analysis: Second Sight Medical Products (EYES) versus Its Rivals
www.americanbankingnews.com - December 5 at 5:28 AM
Reviewing Second Sight Medical Products (EYES) and The CompetitionReviewing Second Sight Medical Products (EYES) and The Competition
www.americanbankingnews.com - December 4 at 3:18 PM
Analyzing Second Sight Medical Products (EYES) & Its RivalsAnalyzing Second Sight Medical Products (EYES) & Its Rivals
www.americanbankingnews.com - December 4 at 9:16 AM
Head-To-Head Review: Second Sight Medical Products (EYES) & Its CompetitorsHead-To-Head Review: Second Sight Medical Products (EYES) & Its Competitors
www.americanbankingnews.com - December 1 at 3:32 AM
ETFs with exposure to Second Sight Medical Products, Inc. : November 30, 2017ETFs with exposure to Second Sight Medical Products, Inc. : November 30, 2017
finance.yahoo.com - November 30 at 5:07 PM
Second Sight Medical Products (EYES) vs. Its Peers Head to Head SurveySecond Sight Medical Products (EYES) vs. Its Peers Head to Head Survey
www.americanbankingnews.com - November 27 at 3:56 PM
Head to Head Survey: Second Sight Medical Products (EYES) & Its CompetitorsHead to Head Survey: Second Sight Medical Products (EYES) & Its Competitors
www.americanbankingnews.com - November 26 at 5:08 AM
Critical Review: Second Sight Medical Products (EYES) versus Its PeersCritical Review: Second Sight Medical Products (EYES) versus Its Peers
www.americanbankingnews.com - November 26 at 1:16 AM
Second Sight Medical Products (EYES) & Its Peers Head-To-Head ReviewSecond Sight Medical Products (EYES) & Its Peers Head-To-Head Review
www.americanbankingnews.com - November 25 at 11:04 PM
Second Sight Medical Products (EYES) & The Competition Critical ComparisonSecond Sight Medical Products (EYES) & The Competition Critical Comparison
www.americanbankingnews.com - November 23 at 9:14 PM
Insider Buying: Second Sight Medical Products, Inc. (EYES) Director Buys 17,020 Shares of StockInsider Buying: Second Sight Medical Products, Inc. (EYES) Director Buys 17,020 Shares of Stock
www.americanbankingnews.com - November 22 at 4:50 AM
ETFs with exposure to Second Sight Medical Products, Inc. : November 20, 2017ETFs with exposure to Second Sight Medical Products, Inc. : November 20, 2017
finance.yahoo.com - November 20 at 7:17 PM
Second Sight Medical (EYES) Says OHTAC Recommends Public Funding for its Argus II Retinal Prosthesis System - StreetInsider.comSecond Sight Medical (EYES) Says OHTAC Recommends Public Funding for its Argus II Retinal Prosthesis System - StreetInsider.com
www.streetinsider.com - November 11 at 8:38 AM
Second Sight Medical (EYES) Announces FDA Expedited Access Pathway Designation for Orion Cortical Visual Prosthesis SystemSecond Sight Medical (EYES) Announces FDA Expedited Access Pathway Designation for Orion Cortical Visual Prosthesis System
www.streetinsider.com - November 10 at 2:40 PM
Second Sight Medical Products, Inc. :EYES-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017Second Sight Medical Products, Inc. :EYES-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017
finance.yahoo.com - November 10 at 2:40 PM
Ontario Health Technology Advisory Committee Recommends Public Funding for Second Sight’s Argus II Retinal Prosthesis SystemOntario Health Technology Advisory Committee Recommends Public Funding for Second Sight’s Argus II Retinal Prosthesis System
finance.yahoo.com - November 10 at 2:40 PM

SEC Filings

Second Sight Medical Products (NASDAQ:EYES) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Second Sight Medical Products (NASDAQ:EYES) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Second Sight Medical Products (NASDAQ EYES) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.